Pharma News - Research & Development News & Articles

601 Novel ACR hybrid score in rheumatoid arthritis applied for the first time to data from the RAPID 1 study with Cimzia (certolizumab pegol) Full Text UCB, February 8, 2013

602 Cimzia (certolizumab pegol) Data Showed Broad and Rapid Relief From Burden of Symptoms In Rheumatoid Arthritis Patients Full Text UCB, February 8, 2013

603 UCB to conduct first anti-TNF head-to-head study between Cimzia (certolizumab pegol) and Humira (adalimumab) Full Text UCB, February 8, 2013

604 Baxter, UCB, TRI-VIZOR and H.Essers announce worlds first example of orchestrated carpooling for cargo Full Text UCB, February 8, 2013

605 Anti-Cancer Agent, Herceptin, Filed for Additional Dosage and Administration for Postoperative Adjuvant Chemotherapy in Breast Cancer By New Drug Application Based on Evidence in the Public Domain Full Text Chugai Pharmaceutical Co., February 8, 2013

606 Two-Year Clinical Study Supports Safety and Efficacy of Covidien Solitaire FR Revascularization Device Full Text Covidien, February 8, 2013

607 New post hoc analyses examined the effects of Neupro (rotigotine) on daytime functioning, daytime symptoms, pain and mood in Restless Legs Syndrome Full Text UCB, February 7, 2013

608 New study finds rheumatoid arthritis (RA) patients preferred ergonomically designed Cimzia (certolizumab pegol) syringe to conventional prefilled syringe Full Text UCB, February 7, 2013

609 New survey finds rheumatoid arthritis patients value personalised goal setting for successful disease management Full Text UCB, February 7, 2013

610 New data for Cimzia (certolizumab pegol) showed a rapid clinical response across a broad population of rheumatoid arthritis (RA) patients Full Text UCB, February 7, 2013

611 Amgen and UCB team up with NASA on final space shuttle mission to conduct preclinical test of sclerostin antibody on bone loss Full Text UCB, February 7, 2013

612 Statement From Sarepta Therapeutics on Stock Volatility Full Text Sarepta Therapeutics, February 7, 2013

613 PhRMA Statement on Clinical Trials and Bad Pharma Full Text PhRMA, February 7, 2013

614 Watson Confirms Opana ER Patent Challenge Full Text Actavis, February 7, 2013

615 Preclinical Study Provides Potential Mechanisms for Lower Cardiotoxicity in Patients with Multiply Relapsed or Refractory Aggressive B-cell NHL Treated with PixuvriTM Who Received Prior Doxorubicin Therapy Full Text Cell Therapeutics, February 7, 2013

616 AHRMM launches new initiative for supply chain professionals Full Text American Hospital Association News, February 7, 2013

617 AHA updates Put It In Writing campaign Full Text American Hospital Association News, February 7, 2013

618 AHA report provides strategies for engaging patients, communities Full Text American Hospital Association News, February 7, 2013

619 2013 AHA Environmental Scan available Full Text American Hospital Association News, February 7, 2013

620 Midwest HIEs Transmitting Among States Health Data Management, February 7, 2013

1 FDA Commissioner Claims Resistance to Compounding Pharmacy Inspections BioPharm International, April 15, 2013    Free full text

2 New Abbott Test Can Help Doctors Detect the Presence of Two Important Health Issues Abbott, March 29, 2013    Free full text

3 Dr. Reddys to Relocate North America HQ BioPharm International, April 11, 2013    Free full text

4 Drug Discovery Initiative Launched in Europe BioPharm International, February 12, 2013    Free full text

5 Sarepta Therapeutics Announces Eteplirsen Demonstrates Sustained Benefit on Walking Test Through 74 Weeks in Phase IIb Study in Duchenne Muscular Dystrophy Sarepta Therapeutics, April 10, 2013    Free full text

6 CHOP Collaborates With Pfizers Centers For Therapeutic Innovation To Speed Pediatric Research & Development Pfizer, April 4, 2013    Free full text

7 FDA launches partnership to protect against counterfeit anti-malarial medicines with FDA-developed handheld detection tool FDA Press Announcements, April 26, 2013    Free full text

8 New research sheds light on NSAID risks American Pharmacists Association News, April 4, 2013    Free full text

9 Mallinckrodt International Finance S.A. Announces Private Offering of Senior Unsecured Notes Covidien, April 10, 2013    Free full text

10 Doctors Agree Small Lifestyle Changes Can Improve Outcomes of Patients with Type 2 Diabetes, National Survey Finds Janssen, March 15, 2013    Free full text

11 ARIAD Presents New Preclinical Data Showing Ponatinib Overcomes Resistant Mutations in KIT, an Oncogenic Driver of Gastrointestinal Stromal Tumors ARIAD Pharmaceuticals, April 10, 2013    Free full text

12 Achieving More Effective and Efficient GMP Auditing BioPharm International, April 3, 2013    Free full text

13 FDA Drug Safety Communication: Azithromycin (Zithromax or Zmax) and the risk of potentially fatal heart rhythms FDA What's New: Drugs, March 15, 2013    Free full text

14 The Future of ACOs Remains Cloudy The Hospitalist, April 11, 2013    Free full text

15 Emerging Outsourcing Trends in 2013 BioPharm International, April 3, 2013    Free full text

16 Medivation and astellas provide update on prevail Astellas, April 5, 2013    Free full text

17 Catalent Biologics Expands Into ADCs BioPharm International, April 12, 2013    Free full text

18 Revolutionary Autoinjector Pushes the Limits of High Viscosity Drug Delivery B3C newswire, April 19, 2013    Free full text

19 AstraZeneca to Cut 1600 Positions in R&D Reorganization BioPharm International, March 22, 2013    Free full text

20 Valeant Pharmaceuticals Announces Private Exchange Offer Valeant Pharmaceuticals International, April 1, 2013    Free full text